The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the cardia trial where they looked at about 5 000 young men starting at age 18 18 to 36. and they looked at people with who had the lowest ldls versus the highest ldls the people had the lowest LDL had the time to first visit for an arthroscrotic event um of like 15 years more than normal whereas the higher the higher the LDL went the sooner and sooner they actually had to see and had an incident event or like that first event
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.